Non invasive evaluation of liver fibrosis in paediatric patients with nonalcoholic steatohepatitis

World J Gastroenterol. 2006 Dec 28;12(48):7821-5. doi: 10.3748/wjg.v12.i48.7821.

Abstract

Aim: To identify the independent predictors of hepatic fibrosis in 69 children with nonalcoholic steatohepatitis (NASH) due to nonalcoholic fatty liver disease (NAFLD).

Methods: All patients with clinically suspected NASH underwent liver biopsy as a confirmatory test. The following clinical and biochemical variables at baseline were examined as likely predictors of fibrosis at histology: age, body mass index (BMI), systolic blood pressure (SBP), dyastolic blood pressure (DBP), fasting glucose, fasting insulin, homeostatic model assessment for insulin resistence (HOMA-IR), cholesterol, tryglicerides, alanine aminotransferase (ALT), aspartate aminotransferase (AST), AST/ALT ratio, gamma glutamil transferase (GT), platelet count, prothrombin time (PT).

Results: At histology 28 (40.6%) patients had no fibrosis and 41 (59.4%) had mild to bridging fibrosis. At multivariate analysis, BMI > 26.3 was the only independent predictor of fibrosis (OR = 5.85, 95% CI = 1.6-21).

Conclusion: BMI helps identify children with NASH who might have fibrotic deposition in the liver.

Publication types

  • Evaluation Study

MeSH terms

  • Adolescent
  • Biopsy
  • Body Mass Index
  • Body Weight / physiology
  • Child
  • Disease Progression
  • Fatty Liver / complications*
  • Fatty Liver / metabolism
  • Fatty Liver / physiopathology*
  • Female
  • Glucose / metabolism
  • Humans
  • Liver / metabolism
  • Liver / pathology
  • Liver / physiopathology
  • Liver Cirrhosis / etiology*
  • Liver Cirrhosis / metabolism
  • Liver Cirrhosis / physiopathology*
  • Male
  • Multivariate Analysis
  • Predictive Value of Tests
  • Risk Factors

Substances

  • Glucose